|
US2742472A
(en)
|
|
1956-04-17 |
|
Spasmolytic pipergzjnes |
|
FR6541E
(fr)
|
|
1906-12-17 |
Paul Charles Louis Aime Joseph |
Chambre d'encolleuse économique à grande production
|
|
BE486462A
(https=)
|
|
|
|
|
|
NL71566C
(https=)
|
1948-10-30 |
|
|
|
|
GB666457A
(en)
|
1948-10-30 |
1952-02-13 |
Henri Morren |
Carbonyl chlorides and monocarboxyamides of piperazine and process for the preparation thereof
|
|
GB748812A
(en)
|
1952-12-15 |
1956-05-09 |
Abbott Lab |
Improvements in or relating to piperazine derivatives and process of preparing the same
|
|
CH333366A
(de)
|
1953-09-04 |
1958-10-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Pyridazone
|
|
DE954155C
(de)
|
1954-01-08 |
1956-12-13 |
Schering Ag |
Verfahren zur Herstellung von 4-Aminochromanen
|
|
GB773756A
(en)
|
1954-08-18 |
1957-05-01 |
Searle & Co |
9-aminoalkyl-9-xanthenecarboxamides and derivatives thereof
|
|
GB781528A
(en)
|
1954-09-10 |
1957-08-21 |
American Cyanamid Co |
Substituted ethylene dipiperazines
|
|
GB778309A
(en)
|
1954-11-12 |
1957-07-03 |
Rhone Poulenc Sa |
4-o.o-diphenyl-phosphorylamido-pyrazolones
|
|
NL92955C
(https=)
|
1954-12-23 |
|
|
|
|
GB777209A
(en)
|
1954-12-28 |
1957-06-19 |
Wellcome Found |
Improvements in or relating to piperazine derivatives
|
|
US2838509A
(en)
|
1956-10-02 |
1958-06-10 |
Searle & Co |
9-aminoalkyl-9-xanthenecarboxamides
|
|
FR1192168A
(fr)
|
1957-04-11 |
1959-10-23 |
|
Préparation de la nu-thiodiphénylcarbamyl piperazine
|
|
US2887481A
(en)
|
1957-04-29 |
1959-05-19 |
Schering Corp |
Heterocyclic amides
|
|
US3284449A
(en)
|
1964-12-29 |
1966-11-08 |
Searle & Co |
Hydrazones of 1-amino-4-xanthenecar-bonylpiperazines
|
|
NL129629C
(https=)
|
1965-07-02 |
|
|
|
|
FR6541M
(https=)
|
1967-05-10 |
1968-12-16 |
|
|
|
US3700658A
(en)
|
1967-07-05 |
1972-10-24 |
Adolf Steinhofer |
N-alkyl-n-arylcarbamoyl lactams
|
|
US3585171A
(en)
|
1967-07-05 |
1971-06-15 |
Basf Ag |
Accelerating the anionic polymerization of lactams
|
|
DE1720281A1
(de)
|
1967-07-05 |
1971-06-09 |
Basf Ag |
Verfahren zum Beschleunigen der anionischen Polymerisation von Lactamen
|
|
DE1770968A1
(de)
|
1968-07-24 |
1972-01-13 |
Bayer Ag |
Verfahren zur Herstellung von Polyamiden
|
|
GB1282336A
(en)
|
1970-03-25 |
1972-07-19 |
Rech S Et D Applic Scient Soge |
Thiaxanthene derivatives and their preparation
|
|
US3803141A
(en)
|
1972-08-14 |
1974-04-09 |
Burdick & Jackson Labor Inc |
10-(1-substituted-3-pyrrolidylmethyl)phenothiazines
|
|
US3838118A
(en)
*
|
1973-02-20 |
1974-09-24 |
Janssen Pharmaceutica Nv |
((thioxanthenyl)propyl)-piperidyl-benzimidazolinones
|
|
FR2218100A1
(en)
*
|
1973-02-20 |
1974-09-13 |
Janssen Pharmaceutica Nv |
Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones
|
|
DE2519583A1
(de)
|
1975-05-02 |
1976-11-18 |
Basf Ag |
Thermoplastische polybutylenterephthalat-formmassen
|
|
JPS5334779A
(en)
|
1976-09-09 |
1978-03-31 |
Kissei Pharmaceut Co Ltd |
Novel piperazine derivatives and thier preparation
|
|
US4188485A
(en)
|
1978-06-16 |
1980-02-12 |
G. D. Searle & Co. |
1-[(10,11-Dihydro-5H-dibenzo[a,d]-cyclohepten-5-yl)methyl]-4-substituted piperidines and related compounds
|
|
CH653675A5
(en)
|
1983-05-26 |
1986-01-15 |
Ciba Geigy Ag |
Microbicides
|
|
DE3607194A1
(de)
|
1986-03-05 |
1987-09-10 |
Merck Patent Gmbh |
Carbamoylphenothiazine
|
|
US4812462A
(en)
|
1986-04-01 |
1989-03-14 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
|
|
US5223508A
(en)
|
1988-12-27 |
1993-06-29 |
Kirin Beer Kabushiki Kaisha |
Pyridyl carboximidamide compounds useful in treating blood pressure
|
|
JPH03251564A
(ja)
*
|
1990-02-26 |
1991-11-11 |
Taisho Pharmaceut Co Ltd |
ジメチルカルバゾール誘導体
|
|
JPH04130429A
(ja)
|
1990-09-21 |
1992-05-01 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
JP2696434B2
(ja)
|
1991-01-23 |
1998-01-14 |
富士写真フイルム株式会社 |
画像形成方法
|
|
JPH04356466A
(ja)
|
1991-01-28 |
1992-12-10 |
Mitsui Toatsu Chem Inc |
新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
|
|
JPH05273701A
(ja)
|
1992-03-26 |
1993-10-22 |
Konica Corp |
ハロゲン化銀カラー写真感光材料
|
|
DE4215213A1
(de)
|
1992-05-09 |
1993-11-11 |
Merck Patent Gmbh |
Arylacetamide
|
|
JPH06211664A
(ja)
|
1993-01-20 |
1994-08-02 |
Pola Chem Ind Inc |
薬剤に対する感受性回復剤
|
|
US5599815A
(en)
|
1993-02-04 |
1997-02-04 |
Meiji Seika Kabushiki Kaisha |
Antipsychotic benzoisothiazolyl piperazine derivatives
|
|
JPH06228095A
(ja)
|
1993-02-04 |
1994-08-16 |
Kirin Brewery Co Ltd |
カルバゾール誘導体
|
|
WO1994022842A1
(en)
|
1993-03-29 |
1994-10-13 |
Basf Aktiengesellschaft |
1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
|
|
DE69422306T4
(de)
|
1993-11-30 |
2000-09-07 |
G.D. Searle & Co., Chicago |
Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzündungen
|
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
|
US6071901A
(en)
*
|
1994-01-04 |
2000-06-06 |
Novo Nordisk A/S |
Substituted dibenz[b,f]azepines and uses thereof
|
|
DE4430091A1
(de)
|
1994-08-25 |
1996-02-29 |
Bayer Ag |
Verwendung von N-substituierten Phenothiazinen
|
|
JPH08110621A
(ja)
|
1994-10-12 |
1996-04-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー感光材料
|
|
JPH08217758A
(ja)
|
1995-02-09 |
1996-08-27 |
Nissan Chem Ind Ltd |
４−ハロアルキルピリミジン−５−カルボン酸アニライド誘導体
|
|
UA54385C2
(uk)
*
|
1995-04-07 |
2003-03-17 |
Ново Нордіск А/С |
N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
|
|
US5795894A
(en)
|
1995-05-02 |
1998-08-18 |
Schering Corporation |
Piperazino derivatives as neurokinn antagonists
|
|
WO1997046549A1
(en)
|
1996-06-05 |
1997-12-11 |
Novartis Ag |
Anti-neurodegeneratively effective xanthene derivatives
|
|
JP2959765B2
(ja)
|
1997-12-12 |
1999-10-06 |
日本たばこ産業株式会社 |
３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
|
|
JPH11292840A
(ja)
|
1998-04-06 |
1999-10-26 |
Soyaku Gijutsu Kenkyusho:Kk |
ノルスタチン誘導体又はその塩
|
|
TW593241B
(en)
|
1999-04-20 |
2004-06-21 |
Hoffmann La Roche |
Carbamic acid derivatives
|
|
EP1236726B1
(en)
|
1999-12-03 |
2004-12-01 |
Ono Pharmaceutical Co., Ltd. |
Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient
|
|
US6436972B1
(en)
|
2000-04-10 |
2002-08-20 |
Dalhousie University |
Pyridones and their use as modulators of serine hydrolase enzymes
|
|
GB0012362D0
(en)
|
2000-05-22 |
2000-07-12 |
Aventis Pharma Ltd |
Chemical compounds
|
|
CA2310205A1
(en)
|
2000-05-29 |
2001-11-29 |
Dalhousie University |
Unknown
|
|
DE10035928A1
(de)
*
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
JP2002047272A
(ja)
|
2000-07-26 |
2002-02-12 |
Dai Ichi Seiyaku Co Ltd |
ポリアミンアミド誘導体
|
|
CA2418720A1
(en)
|
2000-09-13 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
US6727364B2
(en)
|
2001-04-30 |
2004-04-27 |
The Procter & Gamble Company |
Triazole compounds useful in treating diseases associated with unwanted cytokine activity
|
|
AU2003225088A1
(en)
|
2002-04-19 |
2003-11-03 |
Vertex Pharmaceuticals Incorporated |
Regulation of tnf-alpha
|
|
UA79286C2
(en)
*
|
2002-06-29 |
2007-06-11 |
Zentaris Gmbh |
Arylcarbonylpipererazines and heteroarylcarbonylpiperazines and their use in the treatment of benign and malignant tumors
|
|
US7161003B1
(en)
|
2002-09-04 |
2007-01-09 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US8673924B2
(en)
|
2002-09-04 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
US7196078B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
MXPA05002571A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1571146A4
(en)
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
|
US20040147502A1
(en)
|
2002-12-17 |
2004-07-29 |
Bisacchi Gregory S. |
Beta lactam compounds and their use as inhibitors of tryptase
|
|
DE10348023A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
US7700603B2
(en)
|
2003-12-15 |
2010-04-20 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
EP2335701B1
(en)
|
2003-12-15 |
2012-07-11 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7592348B2
(en)
|
2003-12-15 |
2009-09-22 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US9016221B2
(en)
|
2004-02-17 |
2015-04-28 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
|
WO2005111025A1
(en)
|
2004-04-29 |
2005-11-24 |
Aventis Pharmaceuticals Inc. |
3-piperidinylisochroman-5-ols as dopamine agonists
|
|
CA2567080A1
(en)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Ice inhibitors for the treatment of autoinflammatory diseases
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
GB0500300D0
(en)
|
2005-01-07 |
2005-02-16 |
Ionix Pharmaceuticals Ltd |
Chemical compositions
|
|
WO2006105056A2
(en)
|
2005-03-28 |
2006-10-05 |
Fmc Corporation |
Insecticidal 2,4-diaminoquinazolines and related derivatives
|
|
DE102005044813A1
(de)
|
2005-05-19 |
2007-10-04 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
CA2617042A1
(en)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Spiro-cyclic compound
|
|
EP1960364A2
(en)
|
2005-12-07 |
2008-08-27 |
Ramot at Tel-Aviv University Ltd. |
Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
|
|
WO2007076055A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
WO2007098086A2
(en)
|
2006-02-17 |
2007-08-30 |
Avalon Pharmaceuticals |
Hydroxypiperidine derivatives and uses thereof
|
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
|
GB0614365D0
(en)
|
2006-07-19 |
2006-08-30 |
Proaxon Ltd |
Pharmaceutical compositions and their use
|
|
AU2007275415A1
(en)
|
2006-07-20 |
2008-01-24 |
Ligand Pharmaceuticals Incorporated |
Proline urea CCR1 antagonists for the treatment of autoimmune diseases or inflammation
|
|
EP2060563A4
(en)
|
2006-09-08 |
2010-12-22 |
Dainippon Sumitomo Pharma Co |
CYCLIC AMINO ALKYL CY CARBOXYL AMIDE DERIVATIVE
|
|
RU2329044C1
(ru)
|
2006-11-16 |
2008-07-20 |
Андрей Александрович Иващенко |
Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство
|
|
US8202891B2
(en)
|
2007-04-24 |
2012-06-19 |
Theravance, Inc. |
Quaternary ammonium compounds useful as muscarinic receptor antagonists
|
|
JP2011504499A
(ja)
|
2007-11-21 |
2011-02-10 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
トリプターゼ阻害剤として使用するためのスピロピペリジン
|
|
US8017617B2
(en)
|
2007-12-14 |
2011-09-13 |
Theravance, Inc. |
Amidine-containing compounds useful as muscarinic receptor antagonists
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
JP5538239B2
(ja)
|
2008-02-12 |
2014-07-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンゾモルファン及び関連骨格の尿素誘導体、そのような化合物を含む医薬ならびにそれらの使用
|
|
EP2334680A2
(en)
|
2008-08-20 |
2011-06-22 |
Sequoia Pharmaceuticals, Inc. |
Hcv protease inhibitors
|
|
EP2411526A4
(en)
|
2009-03-27 |
2012-09-19 |
Zacharon Pharmaceuticals Inc |
MODULATORS OF GANGLIOSID BIOSYNTHESIS
|
|
WO2010137738A1
(en)
|
2009-05-28 |
2010-12-02 |
Otsuka Pharmaceutical Co., Ltd. |
Heterocyclic compounds for the treatment of stress-related conditions
|
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
|
TW201236239A
(en)
|
2010-11-16 |
2012-09-01 |
Solvay |
Rechargeable metal or metal-ion cell
|
|
JP2012111731A
(ja)
|
2010-11-26 |
2012-06-14 |
Otsuka Pharmaceut Co Ltd |
医薬
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
CN102690717B
(zh)
|
2011-03-24 |
2014-08-20 |
中国石油化工股份有限公司 |
一种极压长寿命汽轮机润滑油组合物
|
|
CA2830958A1
(en)
|
2011-04-06 |
2012-10-11 |
The Scripps Research Institute |
N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
WO2015005901A1
(en)
|
2013-07-09 |
2015-01-15 |
Bristol-Myers Squibb Company |
Combinations of hepatitis c virus inhibitors
|
|
CN103896990B
(zh)
|
2014-03-12 |
2017-02-08 |
石家庄诚志永华显示材料有限公司 |
有机电致发光材料及其应用
|
|
CN104109134A
(zh)
|
2014-06-26 |
2014-10-22 |
陕西科技大学 |
一种n-酰基吩噻嗪及其制备方法
|
|
CN104109133A
(zh)
|
2014-06-26 |
2014-10-22 |
陕西科技大学 |
一种制备n-酰基吩噻嗪的方法
|
|
CN104497013B
(zh)
|
2014-12-11 |
2017-05-31 |
石家庄诚志永华显示材料有限公司 |
氮杂咔唑类oled材料及其制备方法与应用
|
|
CN104557875A
(zh)
|
2015-01-21 |
2015-04-29 |
石家庄诚志永华显示材料有限公司 |
茚并吲哚环状化合物与在有机发光二极管中的应用
|
|
US11084807B2
(en)
*
|
2016-08-18 |
2021-08-10 |
Vidac Pharama Ltd. |
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
|
|
EP4464334A3
(en)
*
|
2016-11-07 |
2025-01-08 |
VIDAC Pharma Ltd. |
Use of compounds for treating hk2-expressing cancers
|
|
US10682346B2
(en)
|
2016-11-07 |
2020-06-16 |
Vidac Pharma Ltd. |
Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
|